Redmile Group’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,450
Closed -$231K 92
2019
Q1
$231K Sell
1,450
-1,500
-51% -$217K 0.01% 76
2018
Q4
$283K Buy
2,950
+780
+36% +$89.3K 0.01% 70
2018
Q3
$307K Hold
2,170
0.01% 76
2018
Q2
$340K Buy
+2,170
New +$341K 0.01% 73
2016
Q2
Sell
-1,053,018
Closed -$33.8M 58
2016
Q1
$33.8M Buy
1,053,018
+94,644
+10% +$3.33M 3.5% 10
2015
Q4
$55.9M Sell
958,374
-184,490
-16% -$9.14M 4.31% 9
2015
Q3
$48.4M Buy
1,142,864
+852,514
+294% +$52.5M 3.66% 11
2015
Q2
$21.2M Buy
+290,350
New +$18.7M 1.74% 22

Other funds holding SAGE